DM
IMCR icon

Deerfield Management’s Immunocore IMCR Stock Holding History

Deerfield Management’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-360,966
Closed -$14.1M – 144
2021
Q2 		$14.1M Buy
360,966
+189,058
+110% +$7.3M 0.25% 95
2021
Q1 		$7.32M Buy
+171,908
New +$7.65M 0.15% 112

Other funds holding IMCR

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Deerfield Management's IMCR Position: Q3 2021 in Review

Deerfield Management sold out of Immunocore (IMCR) in Q3 2021, closing a stake of 360,966 shares — an estimated $14.1M sold.

Deerfield Management first reported a position in IMCR in Q1 2021 and held it in 2 quarters. The position peaked at $14.1M in Q2 2021. 47 funds tracked by Wall St. Rank hold IMCR as of Q3 2021.

  • Deerfield Management reported no remaining Immunocore position as of Q3 2021 after selling out during the quarter.
  • Deerfield Management sold 360,966 Immunocore shares in Q3 2021, an estimated $14.1M.
  • Deerfield Management first reported a position in Immunocore in Q1 2021 and held it in 2 quarters.
  • Deerfield Management's Immunocore position peaked at $14.1M in Q2 2021.
  • 47 funds tracked by Wall St. Rank held Immunocore as of Q3 2021.

Based on Deerfield Management's 13F filing for Q3 2021, filed 15 Nov 2021.